142 related articles for article (PubMed ID: 930747)
1. Brain dopamine turnover and the relief of parkinsonism.
Rinne UK; Sonninen V; Marttila R
Adv Exp Med Biol; 1977; 90():267-75. PubMed ID: 930747
[TBL] [Abstract][Full Text] [Related]
2. Brain dopamine turnover and the relief of parkinsonism.
Rinne UK; Marttila R; Sonninen V
Arch Neurol; 1977 Oct; 34(10):626-9. PubMed ID: 907536
[TBL] [Abstract][Full Text] [Related]
3. Dopaminergic agonist effects on Parkinsonian clinical features and brain monamine metabolism.
Rinne UK; Sonninen V; Marttila R
Adv Neurol; 1975; 9():383-92. PubMed ID: 1096575
[TBL] [Abstract][Full Text] [Related]
4. Brain dopamine receptor stimulation and the relief of Parkinsonism: relationship between bromocriptine and levodopa.
Rinne UK; Marttila R
Ann Neurol; 1978 Sep; 4(3):263-7. PubMed ID: 718139
[TBL] [Abstract][Full Text] [Related]
5. Dopaminergic mechanisms in patients with extrapyramidal disease.
Chase TN; Shoulson I
Adv Neurol; 1975; 9():359-66. PubMed ID: 1146660
[No Abstract] [Full Text] [Related]
6. 14C-homovanillic acid in the cerebrospinal fluid of parkinsonian patients after intravenous 14C-L-dopa.
Extein I; Van Woert M; Roth RH; Bowers MB
Biol Psychiatry; 1976 Apr; 11(2):227-32. PubMed ID: 971447
[TBL] [Abstract][Full Text] [Related]
7. Effects of a dopamine agonist piribedil in depressed patients: relationship of pretreatment homovanillic acid to antidepressant response.
Post RM; Gerner RH; Carman JS; Gillin JC; Jimerson DC; Goodwin FK; Bunney WE
Arch Gen Psychiatry; 1978 May; 35(5):609-15. PubMed ID: 215097
[TBL] [Abstract][Full Text] [Related]
8. Probenecid: dosage, levels in plasma and cerebrospinal fluid (CSF) and influence upon CSF levels of homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA) in the rabbit.
Muizelaar JP; Oberink JI
Psychopharmacologia; 1975 Sep; 43(3):223-7. PubMed ID: 1187954
[TBL] [Abstract][Full Text] [Related]
9. Serotonin and dopamine disturbances in patients with unipolar depression and Parkinsonism.
Mendlewicz J; Vanderheyden JE; Noel G
Adv Exp Med Biol; 1981; 133():753-67. PubMed ID: 6172024
[TBL] [Abstract][Full Text] [Related]
10. Unresponsiveness to L-DOPA in parkinsonian patients: a study of homovanillic acid concentration in the cerebrospinal fluid.
Nishi K; Kondo T; Narabayashi H; Takubo H; Muramoto S; Araki H
J Neurol Sci; 1989 Aug; 92(1):65-70. PubMed ID: 2475587
[TBL] [Abstract][Full Text] [Related]
11. Clinical and pharmacological evaluation of the effects of piribedil in patients with parkinsonism.
McLellan DL; Chalmers RJ; Johnson RH
Acta Neurol Scand; 1975 Jan; 51(1):74-82. PubMed ID: 1091122
[TBL] [Abstract][Full Text] [Related]
12. The effect of valproic acid on the 5-hydroxyindoleacetic, homovanillic and lactic acid levels of cerebrospinal fluid.
MacMillan V; Leake J; Chung T; Bovell M
Brain Res; 1987 Sep; 420(2):268-76. PubMed ID: 2445434
[TBL] [Abstract][Full Text] [Related]
13. Treatment of parkinsonism.
Calne DB; Teychenne PF; Pfeiffer RF
Adv Exp Med Biol; 1977; 90():49-61. PubMed ID: 930750
[No Abstract] [Full Text] [Related]
14. Correlation of clinical symptoms, HVA and 5-HIAA in csf and plasma L-DOPA in Parkinsonian patients treated with L-DOPA and L-DOPA + RO 4-4602.
Campanella G; Algeri S; Cerletti C; Dolfini E; Jori A; Rinaldi F
Eur J Clin Pharmacol; 1977 Apr; 11(4):255-61. PubMed ID: 862646
[No Abstract] [Full Text] [Related]
15. [Dopamine agonists in the therapy of parkinson syndrome].
Kapfhammer HP; Rüther E
Nervenarzt; 1985 Feb; 56(2):69-81. PubMed ID: 3982566
[No Abstract] [Full Text] [Related]
16. Parkinson's disease and amine metabolites in cerebrospinal fluid: implications for L-Dopa therapy.
Korf J; van Praag HM; Schut D; Nienhuis RJ; Lakke JP
Eur Neurol; 1974; 12(5-6):340-50. PubMed ID: 4448192
[No Abstract] [Full Text] [Related]
17. The Parkinson-Control study: a 1-year randomized, double-blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in Parkinson's disease.
Castro-Caldas A; Delwaide P; Jost W; Merello M; Williams A; Lamberti P; Aguilar M; Del Signore S; Cesaro P;
Mov Disord; 2006 Apr; 21(4):500-9. PubMed ID: 16267842
[TBL] [Abstract][Full Text] [Related]
18. Acid monoamine metabolites in the cerebrospinal fluid of Parkinsonian patients treated with levodopa alone or combined with a decarboxylase inhibitor.
Rinne UK; Sonninen V; Siirtola T
Eur Neurol; 1973; 9(6):349-62. PubMed ID: 4712542
[No Abstract] [Full Text] [Related]
19. Parkinson disease treated with a suspected dopamine receptor agonist.
Chase TN; Woods AC; Glaubiger GA
Arch Neurol; 1974 May; 30(5):383-6. PubMed ID: 4821783
[No Abstract] [Full Text] [Related]
20. Juvenile parkinsonism treated with levodopa.
Sachdev KK; Singh N; Krishnamoorthy MS
Arch Neurol; 1977 Apr; 34(4):244-5. PubMed ID: 843258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
